AHR and ovarian cancer: Galangin-loaded biomimetic dendritic cells membrane nanovaccine reprograms the ovarian cancer microenvironment &lt;i&gt;via&lt;/i&gt; Stat3/IDO1/AhR axis to boost immunotherapy.